KRANZLER JAY D has filed 5 insider transactions across 1 company since June 2023.
Most recent transaction: a sale of 61 shares of AVENUE THERAPEUTICS, INC. ($ATXI) on November 05, 2024.
Activity breakdown: 2 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 5, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | KRANZLER JAY D | Director | S | COMMON STOCK, PAR VALUE $0.0001 | 61 | $2.24 | 559.0000 | 341,324 | 9.84% | 0.02% |
| Sept. 27, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | KRANZLER JAY D | Director | P | COMMON STOCK, PAR VALUE $0.0001 | 3 | $2.40 | 123.0000 | 341,324 | 2.50% | 0.00% |
| Sept. 30, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | KRANZLER JAY D | Director | P | COMMON STOCK, PAR VALUE $0.0001 | 497 | $2.50 | 620.0000 | 341,324 | 404.07% | 0.15% |
| Sept. 23, 2024 | AVENUE THERAPEUTICS, INC. | $ATXI | KRANZLER JAY D | Director | A | Employee stock option (right to buy) | 30000 | $0.00 | 30,000.0000 | 341,324 | 9999.99% | 8.79% |
| June 30, 2023 | AVENUE THERAPEUTICS, INC. | $ATXI | KRANZLER JAY D | Director | A | Employee stock option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |